Dentsply Sirona initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business. Wellspect, a provider of bladder and bowel management care products, has an estimated ...

Fintel reports that on February 14, 2025, Wells Fargo initiated coverage of DENTSPLY SIRONA (NasdaqGS:XRAY) with a Equal-Weight recommendation. As of January 29, 2025, the average one-year price ...

(RTTNews) - Dentsply Sirona (XRAY) Tuesday announced the launch of a strategic review process for its Wellspect Healthcare business, a provider of bladder and bowel management products, assessing ...